KIM ANTHONY H. (Chief Financial Officer) received a stock award from MARKER THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/28/2022ACC: 0001209191-22-021394
Officer· Chief Financial Officer
Since Nov 2018
+114.44K
Net shares
Net buyer
$17.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
150.51K acquired · 36.08K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+150.51K
Price / share
—
Trade value
—
% of position
New position
3/24/2022
0.00→150.51K
Common Stock
Direct
Shares
−36.08K
Price / share
$0.48
Trade value
$17.49K
% of position
24.0%
3/24/2022
150.51K→114.44K
Total
Net shares
+114.44K
Net value
-$17.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/24/2022 | A · Award | +150.51K | — | — | New position | 0.00 | 150.51K |
| Common Stock Direct | 3/24/2022 | F · Tax Withholding | −36.08K | $0.48 | $17.49K | 24.0% | 150.51K | 114.44K |
| Total | +114.44K | -$17.49K | ||||||
Derivative Transactions0
No derivative transactions reported